CD8A and colorectal carcinoma: In the CRC and PBMCs, applying SW4869 or co-mutation with SMase2 in the PBRM1 mutant cells reversed the effect of PBRM1 mutation in promoting CD8+ T and cytotoxic NK cells in PMBC.